Gelatinase B functions as regulator and effector in leukocyte biology
- PMID: 11404367
Gelatinase B functions as regulator and effector in leukocyte biology
Abstract
Matrix metalloproteinases (MMPs) form a family of enzymes with major actions in the remodeling of extracellular matrix (ECM) components. Gelatinase B (MMP-9) is the most complex family member in terms of domain structure and regulation of its activity. Gelatinase B activity is under strict control at various levels: transcription of the gene by cytokines and cellular interactions; activation of the pro-enzyme by a cascade of enzymes comprising serine proteases and other MMPs; and regulation by specific tissue inhibitors of MMPs (TIMPs) or by unspecific inhibitors, such as alpha2-macroglobulin. Thus, remodeling ECM is the result of the local protease load, i.e., the net balance between enzymes and inhibitors. Glycosylation has a limited effect on the net activity of gelatinase B, and in contrast to the all-or-none effect of enzyme activation or inhibition, it results in a higher-level, fine-tuning effect on the ECM catalysis by proteases in mammalian species. Fast degranulation of considerable amounts of intracellularly stored gelatinase B from neutrophils, induced by various types of chemotactic factors, is another level of control of activity. Neutrophils are first-line defense leukocytes and do not produce gelatinase A or TIMP. Thus, neutrophils contrast sharply with mononuclear leukocytes, which produce gelatinase A constitutively, synthesize gelatinase B de novo after adequate triggering, and overproduce TIMP-1. Gelatinase B is also endowed with functions other than cleaving the ECM. It has been shown to generate autoimmune neo-epitopes and to activate pro-IL-1beta into active IL-1beta. Gelatinase B ablation in the mouse leads to altered bone remodeling and subfertility, results in resistance to several induced inflammatory or autoimmune pathologies, and indicates that the enzyme plays a crucial role in development and angiogenesis. The major human neutrophil chemoattractant, IL-8, stimulates fast degranulation of gelatinase B from neutrophils. Gelatinase B is also found to function as a regulator of neutrophil biology and to truncate IL-8 at the amino terminus into a tenfold more potent chemokine, resulting in an important positive feedback loop for neutrophil activation and chemotaxis. The CXC chemokines GRO-alpha, CTAP-III, and PF-4 are degraded by gelatinase B, whereas the CC chemokines MCP-2 and RANTES are not cleaved.
Similar articles
-
On the roles of extracellular matrix remodeling by gelatinase B.Verh K Acad Geneeskd Belg. 1997;59(6):489-514. Verh K Acad Geneeskd Belg. 1997. PMID: 9543820 Review.
-
Neutrophil gelatinase B potentiates interleukin-8 tenfold by aminoterminal processing, whereas it degrades CTAP-III, PF-4, and GRO-alpha and leaves RANTES and MCP-2 intact.Blood. 2000 Oct 15;96(8):2673-81. Blood. 2000. PMID: 11023497
-
Chemokines and proteinases in autoimmune diseases and cancer.Verh K Acad Geneeskd Belg. 2002;64(2):105-36. Verh K Acad Geneeskd Belg. 2002. PMID: 12085566 Review.
-
Upregulation of matrix metalloproteinase-9 and tissue inhibitors of metalloproteinases in rapid atrial pacing-induced atrial fibrillation.J Mol Cell Cardiol. 2008 Dec;45(6):742-53. doi: 10.1016/j.yjmcc.2008.07.007. Epub 2008 Jul 23. J Mol Cell Cardiol. 2008. PMID: 18692064
-
Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.Arthritis Res Ther. 2006;8(5):R142. doi: 10.1186/ar2034. Arthritis Res Ther. 2006. PMID: 16919164 Free PMC article.
Cited by
-
VEGF-A recruits a proangiogenic MMP-9-delivering neutrophil subset that induces angiogenesis in transplanted hypoxic tissue.Blood. 2012 Nov 29;120(23):4653-62. doi: 10.1182/blood-2012-04-421040. Epub 2012 Sep 10. Blood. 2012. PMID: 22966168 Free PMC article.
-
No detrimental effects of repeated laparotomies on early healing of experimental intestinal anastomoses.Int J Colorectal Dis. 2005 Nov;20(6):534-41. doi: 10.1007/s00384-004-0731-0. Epub 2005 Apr 5. Int J Colorectal Dis. 2005. PMID: 15809838
-
A role for matrix metalloproteinase-9 in pathogenesis of urogenital Chlamydia muridarum infection in mice.Microbes Infect. 2007 Nov-Dec;9(14-15):1561-6. doi: 10.1016/j.micinf.2007.08.010. Epub 2007 Sep 8. Microbes Infect. 2007. PMID: 18023394 Free PMC article.
-
Matrix metalloproteinase-9 and autoimmune diseases.J Clin Immunol. 2006 Jul;26(4):299-307. doi: 10.1007/s10875-006-9022-6. Epub 2006 May 2. J Clin Immunol. 2006. PMID: 16652230 Review.
-
Dexamethasone, cerebrospinal fluid matrix metalloproteinase concentrations and clinical outcomes in tuberculous meningitis.PLoS One. 2009 Sep 30;4(9):e7277. doi: 10.1371/journal.pone.0007277. PLoS One. 2009. PMID: 19789647 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous